In this webinar, sponsored by IPG Health, we will explore the role that cell and gene therapies can play in treating rare diseases, the unique challenges faced by pharmaceutical companies, healthcare ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

"Connections with Evan Dawson" brings you special rebroadcasts on 1/30/25. First, AI expert Landon Gray on the future of ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

In two new papers, researchers from The Jackson Laboratory (JAX) report the successful use of two approaches—gene therapy and ...

We can do better. We can build a system that provides coordinated high-quality care to every patient who needs it.

In the world of gene therapy, there's a fine line between friend and foe. HIV attacks cells with unparalleled efficiency. But, with a little genomic tweaking, the deadly virus could become an ...

AmplifyBio, a leading preclinical CRO and CDMO played a pivotal role in shaping discussions at Phacilitate’s Advanced Therapy ...

The future of glaucoma research holds tremendous potential for improving diagnosis, treatment, and patient outcomes. It is AI, gene therapy and stem cell which are revolutionizing glaucoma care by ...